at Investor's Business Daily (Wed, 3:35PM)
A U.S. District Judge has accepted a guilty plea from Amgen (AMGN) and approved a $762M settlement to resolve criminal and civil liability arising from its illegal sale and misbranded promotion of Aranesp, which caused false claims to be submitted to Medicare, Medicaid and other government insurance programs. The settlement is the largest ever of its kind to involve a biotechnology firm.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Wed, 10:00AM)
at Investor's Business Daily (Tue, 6:10PM)
at Zacks.com (Fri, 6:25PM)
at Zacks.com (Jan 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs